Provided by Tiger Trade Technology Pte. Ltd.

Entera Bio Ltd.

2.66
+0.16006.40%
Post-market: 2.750.0900+3.38%19:30 EDT
Volume:1.58M
Turnover:4.19M
Market Cap:460.18M
PE:-7.52
High:2.72
Open:2.51
Low:2.51
Close:2.50
52wk High:4.20
52wk Low:0.9100
Shares:173.00M
Float Shares:139.65M
Volume Ratio:2.57
T/O Rate:1.13%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.3536
EPS(LYR):-0.2476
ROE:-138.92%
ROA:-45.98%
PB:63.33
PE(LYR):-10.74

Loading ...

Entera Bio and Opko Health present preclinical data for oral peptides

TIPRANKS
·
Jun 16

Entera Bio reports preclinical EB612 data, targets late-2026 IND filing for hypoparathyroidism program

Reuters
·
Jun 16

Entera Reports Robust Preclinical Data for EB612 (Oral LA-PTH(1-34)) for Hypoparathyroidism and EB618 (Oral GLP-1/Glucagon) for Obesity at ENDO 2026

GlobeNewswire
·
Jun 16

Entera Bio reports Phase 1 data showing single-tablet EB613 matches Forteo PK/PD profile

Reuters
·
Jun 15

ENDO 2026 Oral Presentation Highlights Comparative Clinical Data for Entera’s Breakthrough Single Tablet EB613 (First-in-Class Oral PTH(1-34) Anabolic for Osteoporosis)

GlobeNewswire
·
Jun 15

Entera Bio Is Building the Future of Peptides Beyond the Needle (NASDAQ: ENTX)

TIPRANKS
·
Jun 01

Entera Bio announces annual shareholder meeting notice

Reuters
·
May 15

Analysts Offer Insights on Healthcare Companies: Molina Healthcare (MOH), Entera Bio (ENTX) and Merck & Company (MRK)

TIPRANKS
·
May 11

Entera Bio Faces Elevated Operational Risks Amid Escalating Middle East Geopolitical Tensions

TIPRANKS
·
May 10

Entera Bio files to sell 19.57M ordinary shares for holders

TIPRANKS
·
May 09

Israel's Entera Bio Q1 net loss widens on higher R&D costs

Reuters
·
May 09

Entera Bio Q1 FY26 net loss widens to $3.5 million

Reuters
·
May 09

Entera Bio Q1 EPS $(0.07) Beats $(0.08) Estimate

Benzinga Earnings
·
May 09

Press Release: Entera Announces First Quarter 2026 Financial Results and Updates Across its Oral Peptide Programs

Dow Jones
·
May 09

Entera Bio Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Apr 27